Association of peripheral cytokine levels with cerebral structural abnormalities in schizophrenia

[1]  N. Arsenijević,et al.  Interleukin-6 in Schizophrenia—Is There a Therapeutic Relevance? , 2017, Front. Psychiatry.

[2]  Yong-Ku Kim,et al.  Neuroprotection in Schizophrenia and Its Therapeutic Implications , 2017, Psychiatry investigation.

[3]  Rajiv Radhakrishnan,et al.  The Link Between the Immune System, Environment, and Psychosis. , 2017, Schizophrenia bulletin.

[4]  D. Goldsmith,et al.  A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression , 2016, Molecular Psychiatry.

[5]  M. Saraiva,et al.  Balancing the immune response in the brain: IL-10 and its regulation , 2016, Journal of Neuroinflammation.

[6]  R. Dantzer,et al.  Is there a role for immune-to-brain communication in schizophrenia? , 2016, Psychopharmacology.

[7]  D. Prvulovic,et al.  Cortical thinning in bipolar disorder and schizophrenia , 2016, Schizophrenia Research.

[8]  S. Lui,et al.  A Selective Review of Cerebral Abnormalities in Patients With First-Episode Schizophrenia Before and After Treatment. , 2016, The American journal of psychiatry.

[9]  G. Zunta-Soares,et al.  Interaction of BDNF with cytokines in chronic schizophrenia , 2016, Brain, Behavior, and Immunity.

[10]  I. Melle,et al.  Association between cytokine levels, verbal memory and hippocampus volume in psychotic disorders and healthy controls , 2016, Acta psychiatrica Scandinavica.

[11]  D. Kinney,et al.  Abnormal immune system development and function in schizophrenia helps reconcile diverse findings and suggests new treatment and prevention strategies , 2015, Brain Research.

[12]  R. Lenroot,et al.  Elevated peripheral cytokines characterize a subgroup of people with schizophrenia displaying poor verbal fluency and reduced Broca's area volume , 2015, Molecular Psychiatry.

[13]  S. Rose-John,et al.  Interleukin-6 and its receptors: a highly regulated and dynamic system. , 2014, Cytokine.

[14]  R. Knight,et al.  Insights into Human Behavior from Lesions to the Prefrontal Cortex , 2014, Neuron.

[15]  D. Dwyer,et al.  Divergent effects of first-generation and second-generation antipsychotics on cortical thickness in first-episode psychosis , 2014, Psychological Medicine.

[16]  C. Spencer,et al.  Biological Insights From 108 Schizophrenia-Associated Genetic Loci , 2014, Nature.

[17]  N. Barnes,et al.  Cytokine function in medication-naive first episode psychosis: A systematic review and meta-analysis , 2014, Schizophrenia Research.

[18]  R. Kahn,et al.  Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment , 2014, Schizophrenia Research.

[19]  L. Ellman,et al.  Inflammatory Cytokines and Neurological and Neurocognitive Alterations in the Course of Schizophrenia , 2013, Biological Psychiatry.

[20]  K. Kelley,et al.  Immune–neural connections: how the immune system’s response to infectious agents influences behavior , 2013, Journal of Experimental Biology.

[21]  A. Quintana,et al.  Interleukin-6, a Major Cytokine in the Central Nervous System , 2012, International journal of biological sciences.

[22]  Arno Klein,et al.  101 Labeled Brain Images and a Consistent Human Cortical Labeling Protocol , 2012, Front. Neurosci..

[23]  I. Melle,et al.  Cortical Volume, Surface Area, and Thickness in Schizophrenia and Bipolar Disorder , 2012, Biological Psychiatry.

[24]  S. Rapoport,et al.  Neuroinflammation and Synaptic Loss , 2012, Neurochemical Research.

[25]  I. Melle,et al.  Brain Cortical Thickness and Surface Area Correlates of Neurocognitive Performance in Patients with Schizophrenia, Bipolar Disorder, and Healthy Adults , 2011, Journal of the International Neuropsychological Society.

[26]  B. Kirkpatrick,et al.  Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects , 2011, Biological Psychiatry.

[27]  Anders D. Børglum,et al.  Genome-wide association study identifies five new schizophrenia loci , 2011, Nature Genetics.

[28]  G. Haegeman,et al.  Interleukin-6, a mental cytokine , 2011, Brain Research Reviews.

[29]  J. Grotta,et al.  IL-10 directly protects cortical neurons by activating PI-3 kinase and STAT-3 pathways , 2011, Brain Research.

[30]  H. Nawa,et al.  Cytokine hypothesis of schizophrenia pathogenesis: Evidence from human studies and animal models , 2010, Psychiatry and clinical neurosciences.

[31]  Inês Barroso,et al.  Genome-wide association study identifies five loci associated with lung function , 2010, Nature Genetics.

[32]  Alan S. Brown,et al.  Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. , 2010, The American journal of psychiatry.

[33]  D. Kinney,et al.  A unifying hypothesis of schizophrenia: abnormal immune system development may help explain roles of prenatal hazards, post-pubertal onset, stress, genes, climate, infections, and brain dysfunction. , 2010, Medical hypotheses.

[34]  Christian Gaser,et al.  Reduced cortical thickness in first episode schizophrenia , 2010, Schizophrenia Research.

[35]  A. Dale,et al.  Distinct genetic influences on cortical surface area and cortical thickness. , 2009, Cerebral cortex.

[36]  Ryan Insolera,et al.  Interleukin‐10 provides direct trophic support to neurons , 2009, Journal of neurochemistry.

[37]  R. Kikinis,et al.  Middle and inferior temporal gyrus gray matter volume abnormalities in first-episode schizophrenia: an MRI study. , 2006, The American journal of psychiatry.

[38]  H. Nawa,et al.  Recent progress in animal modeling of immune inflammatory processes in schizophrenia: Implication of specific cytokines , 2006, Neuroscience Research.

[39]  Lars Kai Hansen,et al.  Mining the posterior cingulate: Segregation between memory and pain components , 2005, NeuroImage.

[40]  M. Kringelbach.  The human orbitofrontal cortex: linking reward to hedonic experience , 2005, Nature Reviews Neuroscience.

[41]  Elena Antonova,et al.  The relationship between brain structure and neurocognition in schizophrenia: a selective review , 2004, Schizophrenia Research.

[42]  John H Gilmore,et al.  Prenatal Infection and Risk for Schizophrenia: IL-1β, IL-6, and TNFα Inhibit Cortical Neuron Dendrite Development , 2004, Neuropsychopharmacology.

[43]  E. Rolls,et al.  The functional neuroanatomy of the human orbitofrontal cortex: evidence from neuroimaging and neuropsychology , 2004, Progress in Neurobiology.

[44]  R. Dantzer,et al.  Interleukin-10 in the brain. , 2001, Critical reviews in immunology.

[45]  D. Higgins,et al.  Leukemia Inhibitory Factor and Ciliary Neurotrophic Factor Cause Dendritic Retraction in Cultured Rat Sympathetic Neurons , 1999, The Journal of Neuroscience.

[46]  B. Vogt,et al.  Contributions of anterior cingulate cortex to behaviour. , 1995, Brain : a journal of neurology.

[47]  K. Heese.  Functional repertoire of interleukin-6 in the central nervous system - a review. , 2017, Restorative neurology and neuroscience.

[48]  Chiara S. Haller,et al.  Correlations between brain structure and symptom dimensions of psychosis in schizophrenia, schizoaffective, and psychotic bipolar I disorders. , 2015, Schizophrenia bulletin.

[49]  L. DeLisi,et al.  Speech disorder in schizophrenia: review of the literature and exploration of its relation to the uniquely human capacity for language. , 2001, Schizophrenia bulletin.

[50]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[51]  T. Goldberg,et al.  Cognitive impairment in schizophrenia is the core of the disorder. , 2000, Critical reviews in neurobiology.